Earnings call transcript: First Solar beats EPS in Q1 2026, stock rises

First Solar delivered a strong Q1 2026 beat with EPS of $3.22 vs. $3.08 expected and net income up 65% to a record $347 million, while revenue rose 24% year over year to about $1.0 billion. Gross margin expanded 600 bps to 47% and adjusted EBITDA reached $520 million, though revenue slightly missed consensus by 0.95% and Q2 margin may be pressured by lower Southeast Asia utilization. Shares rose 5.92% aftermarket as management reaffirmed full-year guidance and highlighted benefits from CuRe, domestic manufacturing, and potential tariff-driven pricing support.

Analysis

FSLR’s setup is less about a clean earnings beat and more about the market re-rating a policy-protected cash flow stream. The key second-order effect is that domestic content and trade frictions are turning what used to be a commodity module business into a quasi-regulated supply franchise: the company can monetize scarcity, customer urgency, and tax-credit optimization simultaneously. That creates a wider moat versus imported crystalline-silicon peers, but also means pricing power is increasingly tethered to regulatory outcomes rather than purely end-market demand.

The biggest near-term catalyst is not installed-solar demand; it’s the resolution of tariff and import-rule uncertainty. If the policy framework lands in the company’s favor, the backlog can reprice quickly because customers that have been waiting on the sidelines will be forced to secure supply, and the company’s stated exposure implies meaningful ASP uplift on incremental volume. If the decision disappoints, the market may be underestimating how fast the stock can de-rate because the current margin structure embeds both favorable mix and temporary utilization benefits that are not guaranteed to persist.

The more interesting contrarian angle is that management is implicitly signaling optionality value in Southeast Asia capacity, not core earnings durability. That means the market should not extrapolate current margin strength linearly into 2027: the real asset is the ability to pivot manufacturing geography, not the current run-rate. The perovskite roadmap is strategically bullish but financially dilutive near term; it improves the long-duration tech narrative, yet introduces execution risk and could cap multiple expansion if investors decide the company is becoming a capex-heavy platform rather than a harvest story.

Relative winners are likely domestic supply-chain enablers and U.S.-oriented clean-energy developers that can capture domestic-content benefits, while import-reliant solar OEMs, Southeast Asian module assemblers, and lower-end TOPCon players face structural pressure. TSLA is a wildcard loser if its manufacturing ambitions run into First Solar’s IP enforcement; that doesn’t mean immediate legal damage, but it raises the probability of licensing costs or redesign delay. The market may be underpricing how much of the future margin pool could migrate from module manufacturing to IP rents and policy arbitrage.

Key Decisions for Investors

• Long FSLR vs. short a basket of import-sensitive solar OEMs for 3-6 months; thesis is that policy resolution and domestic-content pricing support relative outperformance, with downside limited by backlog visibility but upside if tariff clarity triggers booking acceleration.
• Add to FSLR on pullbacks rather than chasing strength; best entry is into any pre-policy decision volatility, because the stock is likely to gap on a favorable outcome but can retrace sharply if the framework disappoints.
• Buy FSLR upside calls or call spreads into the expected Section 232 window over the next 4-8 weeks; risk/reward favors convexity because the catalyst is binary and the stock has already demonstrated willingness to re-rate on policy headlines.
• Short-term underweight TSLA against FSLR as an IP-and-domestic-manufacturing hedge; if Tesla accelerates U.S. solar manufacturing, First Solar’s licensing leverage and freedom-to-operate issues become a hidden cost center for Tesla.
• Monitor FSLR into Q3 for signs that margins are flattening as utilization normalizes; if the stock starts discounting 2026 numbers into 2027 without policy support, trim because the current multiple likely over-credits sustainability of peak conditions.